News ACELYRIN acquires ValenzaBio, strengthens immunology positio... ACELYRIN, Inc., a Los Angeles area-based, late-stage clinical biopharma, with additional operations in the San Francisco Bay area,
M&A How to get acquisition ready – a seller’s guide to merger an... This year, the predicted flurry of merger and acquisition (M&A) activity might not have materialised. However, as we near the end of the year, there were some big moves.
News Solid Biosciences acquires AavantiBio, conducts $75 million ... The life sciences company Solid Biosciences is merging with the privately-held gene therapy company AavantiBio in a
News GSK plans $800m US manufacturing investment GSK has made another investment in its manufacturing network, setting aside $800 million to build two plants at its Marietta site in the US.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.